In cancers driven by ALK fusions such as EML4(Echinoderm microtubule-associated protein-like 4)-ALK(+) lung cancer, ALKi+RAFi+MEKi+ERKi treatment was very effective in suppressing tumor cell growth. This evidence concerns the gene ALK and lung carcinoma.